H.C. Wainwright Thinks Cabaletta Bio’s Stock is Going to Recover
May 22 2022 - 04:10AM
TipRanks
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on
Cabaletta Bio (CABA – Research Report) on May 19 and set a price
target of $11.00. The company's shares closed last Friday at $1.42,
close to its 52-week low of $1.17. According to TipRanks.com, Tsao
is a 2-star analyst with an average return of 0.1% and a 39.2%
success rate. Tsao covers the Healthcare sector, focusing on stocks
such as Biohaven Pharmaceutical Holding Co, Cerevel Therapeutics
Holdings, and Praxis Precision Medicines. Currently, the analyst
consensus on Cabaletta Bio is a Strong Buy with an average price
target of $15.33, representing an 829.1% upside.
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-cabaletta-bios-stock-is-going-to-recover-4?utm_source=advfn.com&utm_medium=referral
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Jan 2023 to Feb 2023
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Feb 2022 to Feb 2023